eIFU in the EU: A New Era for Medical Device Documentation

Importance

IFUs provide essential information on safe use, performance and risk mitigation. When these documents are distributed in paper form they often resulting in:

• High printing and distribution costs
• Contribute to environmental impact from paper waste
• Add administrative burdensin maintaining updated versions across different markets

By having e‑IFUs for all professional‑use devices, the EU addresses these challenges. The regulation is not only about cost savings it is about transforming compliance into a dynamic, digital process that supports innovation and competitiveness.

Who Is Covered?

The regulation applies to all medical devices used by healthcare professionals in the EU. This is a significant expansion from previous rules, which limited e‑IFUs to specific categories such as implantable devices or certain in vitro diagnostics.

Now, manufacturers can provide electronic IFUs for surgical instruments, diagnostic equipment or therapeutic device provided they ensure accessibility and provide paper copies upon request.

Benefits of e-IFU for Manufacturers and Healthcare Systems

1. Cost Efficiency

Manufacturers can significantly reduce expenses related to printing, packaging, and logistics. For large companies, the savings are sometime very large, it also frees resources for R&D and market expansion.

2. Environmental Sustainability

The regulation will also contribute to the EU’s Green Deal objectives by reducing paper usage and reducing carbon footprints. Sustainability is no longer optional anymore; it is part of compliance.

3. Real‑Time Updates

Electronic formats allow manufacturers to update IFUs quickly in response to regulatory changes, safety alerts or product modifications. This reduces the risk of outdated information reaching healthcare professionals.

4. Improved Accessibility

Healthcare professionals can access IFUs via secure portals, QR codes or device‑linked platforms. This ensures information is available anytime, anywhere, supporting better clinical decision‑making.

5. Simplified Compliance

Digital documentation streamlines processes such as version control, multilingual updates, and audit readiness. Manufacturers can demonstrate compliance more efficiently during inspections.

Practical Considerations for Manufacturers

Transitioning to e IFU is not just uploading PDFs. Manufacturers must consider:

• Secure Access: Ensuring healthcare professionals can reliably access documents without compromising data integrity.
• Version Control: Maintaining clear records of updates and ensuring obsolete versions are withdrawn.
• Language Requirements: Providing IFUs in all official EU languages relevant to the market.
• Paper copy options: Guaranteeing paper copies are available when requested, especially in settings with limited digital infrastructure.
• Integration with Quality Systems: Aligning e‑IFU processes with ISO 13485 documentation controls and MDR/IVDR requirements.

Challenges and Risks in e-IFU Implementation

While the benefits of e IFU adoption are clear, manufacturers must anticipate and proactively manage several challenges to ensure compliance and safeguard patient safety.:

Digital Divide

Not all healthcare facilities have equal access to digital infrastructure.

• Large hospitals may have strong IT systems, but smaller clinics or rural facilities might not have the same IT support and connectivity.
• Manufacturers must guarantee that paper IFUs remain available upon request, particularly in markets where digital access is unreliable.

Cybersecurity

Cybersecurity risks increases as healthcare systems become increasingly digital.

• Cyberattacks targeting healthcare data are on the rise, making e IFU portals potential entry points.
• Authorities will expect manufacturers to implement encryption, redundancy, access controls, and continuous monitoring leading to increase operation cost.
• Audit readiness requires documented IT risk assessments, penetration test results, and incident response protocols.

Change Management

Shifting from paper to digital requires investment in people, processes and culture.

• Regulatory, quality and IT teams must be trained on new workflows, version control, and multilingual management.
• Healthcare professionals accustomed to paper formats may resist digital alternatives. Clear communication and user friendly access methods are essential to drive adoption.
• SOPs must be revised to cover e IFU creation, updates, vigilance reporting, and audits.
• Initial investment in IT infrastructure and training may significant high.

Regulatory Oversight

Authorities will closely monitor implementation to ensure patient safety is not compromised.

• IFUs must still be provided in all official EU languages relevant to the market. Digitalisation does not reduce translation obligations.
• Regulators will expect manufacturers to demonstrate that obsolete IFUs are withdrawn but remain accessible upon request.
• Integration with EUDAMED and linkage to UDI identifiers will be scrutinized to ensure transparency.
• Notified bodies will require documented risk assessments, validation reports, and version histories to confirm conformity.

Regulatory Requirements

1. Conducting a Risk Assessment

Manufacturers must evaluate whether e IFUs are appropriate for their intended professional users. This includes assessing usability, accessibility and cybersecurity risks. The risk assessment should be documented and integrated into the Quality Management System (QMS).

2. Validating Digital Platforms

Digital platforms hosting e IFUs must be validated to ensure reliability, security and compliance with GDPR. Manufacturers should implement version control, audit trails and redundancy to guarantee uninterrupted access.

3. Updating Device Labelling

Labels must include clear instructions on how to access e IFUs through URLs, QR codes or UDI links. Consistency across packaging, IFU and EUDAMED entries is crucial. Manufacturers must also prepare workflows for providing paper IFUs upon request.

4. EUDAMED Integration

Manufacturers should prepare to upload e IFU URLs to the UDI database once mandatory registration begins. UDI/e IFU linkage is required for traceability and must align with MDR Article 27. It’s not optional once EUDAMED modules are fully functional.

5. Document Control

All IFU versions must be archived with dates of issue. Obsolete versions must remain accessible upon request. Document control processes should align with ISO 13485 and MDR requirements.

6. Train Staff and Update SOPs

Regulatory, quality, and IT teams must be trained on e IFU workflows. Standard Operating Procedures (SOPs) should be updated to cover document creation, updates, vigilance reporting, and audits. Multilingual IFU management must be included.

7. Ensuring Audit Readiness

Manufacturers should integrate e IFU compliance into internal audit schedules. Evidence of conformity—including risk assessments, validation reports, and version histories—must be readily available for notified body inspections.

8. Communicate with Stakeholders

Distributors, healthcare facilities, and notified bodies must be informed about e IFU adoption. Clear instructions for accessing electronic IFUs should be provided, along with support channels for paper IFU requests.

9. Cybersecurity

Secure hosting solutions with redundancy must be implemented. Access controls, encryption, and monitoring systems should be in place to protect against unauthorized access or tampering. Manufacturers must ensure redundancy and monitoring systems to prevent interruption, as regulators will expect evidence of IT risk management.

10. Transitional Devices

Transitional devices under MDR Article 120 are explicitly covered, ensuring continuity for products still on the market under certificates issued under the old directives.

11. Engage Strategically

Manufacturers should participate in EU consultations and industry forums to stay ahead of evolving guidance. Monitoring updates from MedTech Europe, EUR Lex, and regulatory authorities is essential.

Comparison of e IFU Requirements across different countries

Strategic Implications for Industry

Competitive Advantage

Early adopters of e IFU can position themselves as leaders in sustainability and innovation, strengthening their market reputation.

Regulatory Alignment

Digital documentation simplifies compliance demonstrations during audits and inspections, reducing administrative burdens.

Market Expansion

By streamlining documentation, manufacturers can allocate more resources to R&D and global market entry.

Conclusion

The adoption of Regulation (EU) 2025/1234 marks a decisive step toward digitalisation, sustainability, and efficiency in medical device regulation. By allowing e IFUs for all professional use devices, the EU empowers manufacturers to modernise compliance while supporting healthcare systems in delivering safer, more efficient care.

Paper IFUs remain available on request, ensuring inclusivity, but the default is now digital. This balance reflects the EU’s pragmatic approach: embracing innovation while safeguarding accessibility.

With the enforcement date set for July 2026, manufacturers must act now. Risk assessments, system validation, labelling updates, EUDAMED integration, document control, training and audit readiness are all critical steps to complete before June 2026.

Reference

https://eur-lex.europa.eu/eli/reg_impl/2025/1234/oj/eng

https://meddeviceguide.com/blog/electronic-instructions-for-use-eifu-medical-device-eu-mdr-fda-guide

Need Expert Support with eIFU Compliance?

Prepare your medical device documentation for Regulation (EU) 2025/1234 with expert guidance from Sushvin. Our team supports manufacturers with regulatory strategy, technical documentation, labelling review, risk assessment, and compliance readiness for EU medical device requirements.

Explore Sushvin’s Regulatory Services

Contact Sushvin For Best Quality and Regulatory Services for Medical Devices & Pharmaceutical Industries in UK, Europe

Stay informed with the latest insights, updates, and expert tips - subscribe to our monthly newsletter today!

Email us at info@sushvin.com | Medical Device Regulatory Updates - Monthly Newsletter | SUSHVIN Consultancy